Technology
Clinical Diagnostics
CEA Testing & Monitoring
Defense
Environmental

PULLING DATA
OUT OF THIN AIR

Identify VOCs in seconds—on the spot

These VOCs are indicative of substances important to many industries that include:

Clinical diagnostics
Cannabis testing & monitoring
Defense
Environmental

RingIR, Inc. (DBA Agnoscis Molecular) was founded in 2013 by Charles Harb, PhD in Canberra, Australia and in 2016 established a base in Albuquerque, NM.

Agnoscis Molecular has developed advanced spectroscopic technology that in seconds detects Volatile Organic Compounds (VOCs) in breath, sweat, or urine with a sensitivity that is 1,000,000 times more sensitive than standard (absorption) spectroscopy.

+ Clinical diagnostics

+Cannabis testing

Agnoscis Molecular’s technology is a proprietary spectroscopic technique called real time cavity ring down spectroscopy (rtCRDS).

Clinical
diagnostics

Our first product is a non-invasive COVID diagnostic breath test. The breath test will be very low cost, give results in 10 seconds, and is unaffected by COVID variants.

Beyond COVID diagnostics, the company plans to develop two multiplex panels that will simultaneously identify the presence of:

Respiratory diseases, including COVID-19, Flu A, Flu B, and RSV
Drugs of abuse, e.g., fentanyl, morphine, cocaine, etc.

In seconds our highly sensitive medical platform technology can detect and quantify in gaseous samples of breath (or heated urine or sweat) VOCs that are products of COVID, other respiratory infections, and drugs of abuse. Agnoscis Molecular was chosen by the NIH’s Rapid Acceleration of Diagnostics (RADx) to bring this non-invasive technology to the world.

Meet Odin

Agnoscis Molecular’s technology is a proprietary spectroscopic technique called real time cavity ring down spectroscopy (rtCRDS). A key component is a Quantum Cascade Mid IR Laser. Within 10 seconds, this extremely sensitive technology can detect compounds within 100 parts/trillion. It can also detect more than 100 different VOCs at once.

Odin Provides:

PEACE OF MIND AND PREPAREDNESS Bad information is worse than no information.
Precise molecule identification Unique molecular fingerprint identification means you know what you are dealing with.
In-situ operation and rapid feedback Be proactive instead of reactive with the information you need to make critical decisions.
Central control and monitoring Odin uses modern IOT and AI to enable site-wide overview from a central location.

Controlled Environment Agriculture —
Monitoring & Testing

In February 2022, KD Market Insights reported that globally, the CEA market is projected to increase from more than $74 billion in 2020 to an estimated more than $172 billion in 2025. In May 2022, Precedence Research reported that globally, the superfoods market is projected to increase from US$ 161.11 billion reached in 2021 to an expected estimated US$ 246.2 billion by 2030.

Many superfoods and high value crops lend themselves to indoor environments such as Greenhouse Hydroponics, CEA Aquaponics, CEA Container Farming, and CEA Hydroponics. Even under controlled environment conditions however, growers have challenges achieving high yields, quality, and consistency for virtually any crop, and the various forms of CEA systems create new scenarios where pests and disease can thrive. As farmers battle these new challenges, high tech solutions have risen to monitor and control humidity, air flow, temperature, and lighting in hopes of preventing threats to successful crop production. Yet, no environment, is 100% protected.

Farmers must keep close watch over their crops so that pest and disease issues can be identified and managed early. It is vital to understand the local environment surrounding each plant, i.e., the “microenvironment” of the plant.

Agnoscis Molecular’s technology is ideally suited to monitor the “microenvironment” next to the growing leaves, measuring the presence of elements of concern. Harvested crops can be tested to ensure freshness and quality to meet internal specifications and to be released for additional production or packaging.

Analytics

Because the vast majority of Agnoscis Molecular’s customers will use both our growth monitoring and testing, we will create a unique database of growth parameters linked to tangible growth improvement outcomes for product optimization—an obviously valuable commodity to producers that only Agnosicis Molecular can provide due to our sole ability to non-invasively gather data on site, from seedling to production. This data will be gathered from inception to create viable data analytics.

Cannabis Monitoring
& Testing

We are currently piloting growth monitoring to selected cannabis producers who strive to optimize the yields of their frequent harvests. Producers can use an AG-2000 on site to assay the air around the plant—without disruption to the growing plant—to measure THC, CBD, and potentially other parameters as well. Our cloud-based technicians will interpret the transmitted sample data and report results back to the producer in the same day.

Cannabis plants are extremely valuable. Frequent monitoring of process parameters once or twice a day is critical. Agnoscis Molecular has the only technology that can quickly and accurately quantify THC (and associated cannabinoids) without destroying the plant. After harvest and/or production, pre-batch release testing can be performed to ensure all quality standards have been met prior to delivery to a Certified Lab for COA.

DEFENSE

Agnoscis Molecular has demonstrated the strength of its technology in identifying gaseous substances of interest both to the US and the Australian Defense Departments.

ENVIRONMENTAL

The company has, for example, demonstrated to the Woods Hole Oceanographic Institution that it can detect and track a methane leak on the ocean floor (2000m below sea level) from 13 kilometers away.

LEADERSHIP

Charles Harb

PhD, CEO, Founder & Chairman. Professor at University of NSW Australia; expert in interferometry and quantum optics

Dr. Charles Harb is a noteworthy leader in the field of advanced interferometry and quantum optics with a distinguished research career. In 2013, Dr. Harb founded RingIR to commercialize the rtCRDS technology developed in his laboratories at the University of New South Wales, Canberra, Australia.

Anna Harb

COO, Founder & Director; experienced in business infrastructure

Anna has more than 35 years of experience specializing in office management, facilities management, and staffing, including significant time working in business and tech start-ups in Silicon Valley. She is responsible for the company’s administrative processes and functions essential for growth.

Gregory Zaic

MS, MS: NIH RADx business advisor; 25+ years as a medically focused venture capitalist; former Baxter Labs executive

Gregory has 25+ years of private equity investment and business development experience. He has served on 23 boards of directors in a broad range of fields including medical technology, pharma, and technology and has managed 7 venture capital funds totaling over $160 million as a general partner.

Leyla Kara

NIH RADx Project Manager

Leyla is an experienced project management and supply chain specialist working in energy, oil & gas, and medical devices industries. Leyla has been responsible for strategy, global sales, marketing, and quality control for various technology enterprises such as OraSure, Technologies, Worley, Fenton Technologies Canada, and many other.

Robert Tufts

Director, Cuyler Tufts Law

Robert has extensive experience in general corporate representation, with an emphasis on financing, mergers and acquisitions, and corporate taxation. He serves or has served as director/officer for various corporations including Autodesk, Cardinal Sound Labs, NovaBay Pharmaceuticals, and many more.

Tom Brennan

Director, Arch Venture Partner; experienced entrepreneur and investo

Tom has extensive expertise and experience in technology, entrepreneurship, investment, strategic alliances, and government policy. From 2008-2021 Tom Brennan was a Venture Partner at ARCH. He has published more than 120 articles and holds twelve patents issued and pending.

Pierre Khuri-Yakub

Director, Entrepreneur, Professor of Electrical Engineering at Stanford University

Professor of Electrical Engineering at Stanford University, Pierre has authored more than 600 publications and has been principal inventor or co-inventor of 103 issued patents. Current research interests include medical ultrasound imaging and therapy, chemical/biological sensors, and gas flow and energy flow sensing.